IGF::OT::IGF To develop HemoDefend, hemocompatible, highly porous polymer beads optimized to broadly remove freehemoglobin, potassium, reactive antibodies, and inflammatory or reactive substances from
$774,516N44FY2016HLNIH
Cytosorbents, Inc., Princeton NJ
Investigators
Abstract
To develop HemoDefend, hemocompatible, highly porous polymer beads optimized to broadly remove free hemoglobin, potassium, reactive antibodies, and inflammatory or reactive substances
View original record on NIH RePORTER →